MktsMarkets

BridgeBio Pharma, Inc.
NASDAQ: BBIOKey statistics
BBIO News
Stories mentioning BBIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 194,515 | 154,178 | 120,700 | 110,565 | 116,633 | 5,882 | 2,732 | 2,168 |
| Cost of Goods Sold | 9,939 | 8,107 | 6,563 | 3,653 | 2,639 | 2,084 | 598.00 | 598.00 |
| Gross Profit | 184,576 | 146,071 | 114,137 | 106,912 | 113,994 | 3,798 | 2,134 | 1,570 |
| Operating Expenses | ||||||||
| Research & Development | 126,636 | 116,417 | 112,874 | 111,231 | 111,431 | 130,350 | 120,444 | 114,695 |
| Sales General & Admin | 163,896 | 158,085 | 137,621 | 129,154 | 106,365 | 94,782 | 68,819 | 59,523 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (105,956) | (139,562) | (145,199) | (134,278) | (104,372) | (226,027) | (191,750) | (175,539) |
| Interest Income | 6,246 | 4,332 | 6,239 | 3,898 | 5,385 | 4,683 | 3,296 | 5,195 |
| Interest Expense | 22,937 | |||||||
| Other Expense | 4,253 | 11,818 | 16,461 | 6,548 | 8,231 | 1,624 | 1,797 | (632.00) |
| Pretax Income | (186,482) | (181,658) | (164,254) | (75,544) | ||||
| Tax Provision | (120.00) | (1,545) | 2,100 | 0.00 | 1,153 | 0.00 | 0.00 | |
| Net Income (Loss) | ||||||||
| Earnings Per Share (Basic) | (0.84) | 0.00 | (0.95) | (0.95) | (0.88) | 0.00 | (0.86) | (0.39) |
| Earnings Per Share (Diluted) | (0.84) | 0.00 | (0.95) | (0.95) | (0.88) | 0.00 | (0.86) | (0.39) |
| Weighted Average Shares Outstanding (Basic) | 194,790 | 191,527 | 191,854 | 190,517 | 190,145 | 186,076 | 188,510 | 187,587 |
| Weighted Average Shares Outstanding (Diluted) | 194,790 | 191,527 | 191,854 | 190,517 | 190,145 | 186,076 | 188,510 | 187,587 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BBIO
BridgeBio Pharma, Inc. (NASDAQ: BBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol BBIO. It last traded at $78.67 (Nov 10, 2026, 4:00 PM ET), up 0.9% on the day. That gives BridgeBio Pharma a market capitalisation of $15.5B.
Over the past 52 weeks BBIO has traded between $60.55 and $93.42.
Revenue for the quarter ended Mar 31, 2026 was $194.5M. Revenue was up 66.8% from $116.6M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | $194.5M | — |
| Dec 31, 2025 | $154.2M | — |
| Sep 30, 2025 | $120.7M | — |
| Jun 30, 2025 | $110.6M | — |
From BridgeBio Pharma’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…